| Long-term voluntary exercise and the mouse hypothalamic-pituitary-adrenocortical axis: impact of concurrent treatment with the antidepressant drug tianeptine. | |
| | |
MedLine Citation:
|
PMID: 17076767 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We investigated whether voluntary exercise and concurrent antidepressant treatment (tianeptine; 20 mg/kg/day; 4 weeks) exert synergistic effects on the mouse hypothalamic-pituitary-adrenocortical (HPA) axis. Animals had access to a running wheel, were treated with the antidepressant, or received both conditions combined. Control mice received no running wheel and no drug treatment. Exercise resulted in asymmetric changes in the adrenal glands. Whereas sedentary mice had larger left adrenals than right ones, this situation was abolished in exercising animals, mainly due to enlargement of the right adrenal cortex. However, antidepressant treatment alone was ineffective whereas the combination of antidepressant treatment and exercise resulted in an enlargement of both adrenal cortices. In these respective conditions, the levels of tyrosine hydroxylase (TH) mRNA expression in the left and right adrenal medullas varied greatly in parallel to the changes observed in the adrenal cortex sizes. TH mRNA expression in the locus coeruleus of exercising mice was significantly increased irrespective of concomitant tianeptine treatment. Corticotrophin-releasing factor mRNA levels in the hypothalamic paraventricular nucleus were decreased after voluntary exercise but were unaffected by tianeptine. Exercise, particularly in combination with tianeptine treatment, resulted in decreased early morning baseline plasma levels of corticosterone. If animals were exposed to novelty (i.e. a mild psychological stressor), a decreased response in plasma corticosterone levels was observed in the exercising mice. By contrast, after restraint, a mixed physical and psychological stressor, exercising mice showed an enhanced response in plasma corticosterone compared to the controls; a response which was even further boosted in exercising mice concomitantly treated with tianeptine. Under either condition, plasma adrenocorticotrophic hormone levels were not different between groups. Thus, voluntary exercise impacts substantially on HPA axis regulation. Concurrent tianeptine treatment results in synergistic actions, mainly at the adrenal level, affecting both its structure and function. |
| | |
Authors:
|
S K Droste; M C Schweizer; S Ulbricht; J M H M Reul |
Related Documents
:
|
22804927 - Hemodynamic, echocardiographic, and exercise-related effects of the heartware left vent... 23610057 - Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel ... 22951107 - Glutamatergic neurotransmission in the hypothalamus pvn on heart rate variability in ex... 22858247 - An exaggerated blood pressure response to treadmill exercise does not increase the like... 423187 - Relationship of nonspecific antiarrhythmic and negative inotropic activity with physico... 10613417 - Adverse events associated with eccentric exercise protocols: six case studies. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Journal of neuroendocrinology Volume: 18 ISSN: 0953-8194 ISO Abbreviation: J. Neuroendocrinol. Publication Date: 2006 Dec |
Date Detail:
|
Created Date: 2006-11-01 Completed Date: 2007-01-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8913461 Medline TA: J Neuroendocrinol Country: England |
Other Details:
|
Languages: eng Pagination: 915-25 Citation Subset: IM |
Affiliation:
|
Max Planck Institute of Psychiatry, Section of Neuropsychopharmacology, Munich, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenal Cortex
/
anatomy & histology,
drug effects,
physiology Analysis of Variance Animals Antidepressive Agents, Tricyclic / pharmacology* Choice Behavior Circadian Rhythm / drug effects Corticosterone / blood Corticotropin-Releasing Hormone / genetics, metabolism Hypothalamo-Hypophyseal System / drug effects*, metabolism Locus Coeruleus / drug effects, metabolism Male Mice Mice, Inbred C57BL Organ Size Paraventricular Hypothalamic Nucleus / drug effects, metabolism Physical Conditioning, Animal / physiology* Pituitary-Adrenal System / drug effects*, metabolism RNA, Messenger / analysis Thiazepines / pharmacology* Time Factors Tyrosine 3-Monooxygenase / genetics, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents, Tricyclic; 0/RNA, Messenger; 0/Thiazepines; 50-22-6/Corticosterone; 66981-73-5/tianeptine; 9015-71-8/Corticotropin-Releasing Hormone; EC 1.14.16.2/Tyrosine 3-Monooxygenase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: In the ventral tegmental area, cyclic AMP mediates the actions of progesterone at dopamine type 1 re...
Next Document: Response of interleukin-1beta in the magnocellular system to salt-loading.